Key result
Transmembrane segment IIIS2 of the human alpha 1C subunit, regulated by alternative splicing, determines the sensitivity of Ca2+ channel splice variants to dihydropyridines.
Identifies the specific amino acids in the IIIS2 segment of the human L-type calcium channel alpha 1C subunit responsible for differential sensitivity to dihydropyridines.
Answers are grounded in this paper and cite their sources.
May guide isoform-selective dihydropyridine design; leaves open clinical relevance of IIIS2 splicing in human disease.
Voltage-dependent inhibition by 1,4-dihydropyridines is a characteristic property of L-type Ca2+ channels. Six out of 50 exons of the channel alpha 1C subunit gene are subjected to alternative splicing, thus generating channel isoform diversity. Using Xenopus oocytes as an expression system, we have found that transmembrane segment IIIS2 of human alpha 1C subunit is involved in the control of voltage dependence of dihydropyridine action. This segment is genetically regulated through alternative splicing of exons 21/22. Site-directed mutagenesis points to two amino acids in IIIS2, which determine the difference of the splice variants in their sensitivities to dihydropyridines. This finding provides new insight into molecular mechanisms of Ca2+ channel inhibition by this important class of drugs.
No takes yet. Share an insight, caveat, or question.
Soldatov et al. (1995) studied this question. 1,4-dihydropyridines was evaluated on Voltage-dependent inhibition of Ca2+ channel splice variants. Transmembrane segment IIIS2 of the human alpha 1C subunit, regulated by alternative splicing, determines the sensitivity of Ca2+ channel splice variants to dihydropyridines.
Synapse has enriched 10 related papers. Consider them for comparative context: